本页面由Tiger Trade Technology Pte. Ltd.提供服务

Recursion Pharmaceuticals, Inc.

2.83
+0.10503.86%
盘后:2.870.0450+1.59%19:59 EST
成交量:4,120.52万
成交额:1.18亿
市值:17.59亿
市盈率:-3.16
高:3.02
开:2.79
低:2.77
收:2.72
52周最高:5.24
52周最低:2.50
股本:6.23亿
流通股本:6.06亿
量比:1.80
换手率:6.80%
股息:- -
股息率:- -
每股收益(TTM):-0.8945
每股收益(LYR):-1.4410
净资产收益率:-48.72%
总资产收益率:-23.89%
市净率:1.94
市盈率(LYR):-1.96

数据加载中...

2026/11/13

超过5%披露

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2026/11/10

超过5%披露

Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
2026/11/03

关联方拟减持公告

Form 144 | Recursion Pharmaceuticals董事 Blake Borgeson拟减持40000股,总价约15.5万美元
2026/11/03

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2026/11/03

重要事件披露

Form 8-K - Current report
2026/10/15

重要事件披露

Form 8-K - Current report
2026/10/06

关联方拟减持公告

Form 144 | RECURSION PHARMACEUTICALS 董事 Borgeson Blake 拟减持50000股,总价约24.2万美元
2026/10/06

关联方拟减持公告

Form 144 | Recursion Pharmaceuticals董事Robert Hershberg拟减持25000股,总价约12.5万美元
2026/09/21

重要事件披露

Form 8-K - Current report
2026/09/08

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/09/02

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/08/21

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/08/20

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/08/19

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/08/18

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/08/13

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/08/12

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/08/10

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/08/07

超过5%披露

Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
2026/08/07

关联方拟减持公告

Form 144 - Report of proposed sale of securities